Skip to main content
TTRX logo

TTRX · Turn Therapeutics Inc.

$7.49 -0.21 (-2.73%)
Market Cap
$229.37M
Shares
29.79M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
44/100
Short interest 0.2% of shares — P25 Days to cover 1.0 — P13 Price vs VWAP +1.7% — P63 Short-volume trend +15.8% — P87 Short interest change +49.9% — P90 Worst FTD 0.00% of shares — P28

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-08-14 Scheduled
FINRA publishes Aug 25
2026-07-31 Scheduled
FINRA publishes Aug 11
2026-07-15 57,729 38,506 +19,223 1.00
2026-06-30 38,506 30,684 +7,822 1.00
2026-06-15 30,684 63,729 -33,045 1.00
2026-05-29 63,729 64,613 -884 1.00
2026-05-15 64,613 51,417 +13,196 2.82
2026-04-30 51,417 60,219 -8,802 2.48
2026-04-15 60,219 63,128 -2,909 1.71
2026-03-31 63,128 66,046 -2,918 3.12
2026-03-13 66,046 70,807 -4,761 3.35
2026-02-27 70,807 76,967 -6,160 4.49
2026-02-13 76,967 81,599 -4,632 3.43
2026-01-30 81,599 69,954 +11,645 2.05
2026-01-15 69,954 60,709 +9,245 1.09
2025-12-31 60,709 5,671 +55,038 1.00
2025-12-15 5,671 24,347 -18,676 1.00
2025-11-28 24,347 53,542 -29,195 1.00
2025-11-14 53,542 101,458 -47,916 1.00
2025-10-31 101,458 127,098 -25,640 1.00
2025-10-15 127,098 0 +127,098 1.00
Showing 1–19 of 19 settlements
Key facts CIK 2023016 CUSIP 90021W105 13F (30d) 7 filings 7 filers Visit website Investor relations